Načítá se...
Personalized exon skipping strategies to address clustered non-deletion dystrophin mutations
Antisense oligomer induced exon skipping is showing promise as a therapy to reduce the severity of Duchenne Muscular Dystrophy. To date, the focus has been on excluding single exons flanking frame-shifting deletions in the dystrophin gene, however, a third of all Duchenne Muscular Dystrophy causing...
Uloženo v:
| Hlavní autoři: | , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2010
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2991584/ https://ncbi.nlm.nih.gov/pubmed/20817455 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nmd.2010.07.276 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|